Dynamic Light Scattering: A Tool to Accelerate Oncolytic Vaccine Development
This case study highlights the significance of particle size analysis via Dynamic Light Scattering (DLS) in the development of vaccines based on the MVA virus.
The Process Development Blog
Cutting edge process development insights and news from APC.
-
Read More
-
Irish company APC partners with Australian biotechnology firm Vaxine to accelerate the development and delivery of new Covid-19 vaccine candidate
Read MoreAPC and Vaxine partner to accelerate development of COVAX-19, combining BioACHIEVE process development with Advax adjuvant technology to reduce vaccine timelines.
Explore By
Related Services
Power Up Your Process Development Knowledge
Receive actionable process development insights and explore cutting edge process development news with great science delivered to your inbox every couple of months.